Talant Sooronbaev

Abstract COPD remains a major health burden worldwide, with adherence to inhaled therapy being a key determinant of treatment success. The Test of Adherence to Inhalers (TAI) is a validated tool for assessing adherence, but does not provide tailored interventions. The TAI Toolkit was developed to address this gap by offering individualized adherence-enhancing strategies. We aimed to assess the usability of the TAI Toolkit among healthcare professionals in Kyrgyzstan.

Introduction The Global Burden of Disease Study reported a prevalence of 251 million cases of chronic obstructive pulmonary disease (COPD) globally in 2016.1 Of those, more than 90% of COPD deaths occur in low- and middle-income countries (LMIC). The primary cause of COPD is exposure to tobacco smoke (either active smoking or secondhand smoke). Other risk factors include exposure to indoor and outdoor air pollution and occupational dusts and fumes.